AEGON ASSET MANAGEMENT UK Plc lowered its stake in Morgan Stanley (NYSE:MS – Free Report) by 10.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 644,731 shares of the financial services provider’s stock after selling 72,126 shares during the period. Morgan Stanley makes up approximately 1.4% of AEGON ASSET MANAGEMENT UK Plc’s holdings, making the stock its 16th largest holding. AEGON ASSET MANAGEMENT UK Plc’s holdings in Morgan Stanley were worth $105,339,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Brighton Jones LLC grew its position in Morgan Stanley by 10.2% during the 4th quarter. Brighton Jones LLC now owns 12,782 shares of the financial services provider’s stock worth $1,607,000 after acquiring an additional 1,185 shares during the last quarter. Main Street Financial Solutions LLC increased its stake in Morgan Stanley by 69.0% in the 2nd quarter. Main Street Financial Solutions LLC now owns 8,964 shares of the financial services provider’s stock worth $1,263,000 after purchasing an additional 3,661 shares during the period. Diversify Advisory Services LLC lifted its position in Morgan Stanley by 90.9% in the second quarter. Diversify Advisory Services LLC now owns 16,148 shares of the financial services provider’s stock valued at $2,378,000 after purchasing an additional 7,688 shares during the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lifted its position in Morgan Stanley by 6.3% in the second quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 263,575 shares of the financial services provider’s stock valued at $37,127,000 after purchasing an additional 15,623 shares during the last quarter. Finally, Jupiter Wealth Management LLC boosted its stake in shares of Morgan Stanley by 7.8% during the second quarter. Jupiter Wealth Management LLC now owns 52,825 shares of the financial services provider’s stock valued at $7,805,000 after purchasing an additional 3,807 shares during the period. Institutional investors own 84.19% of the company’s stock.
Morgan Stanley News Roundup
Here are the key news stories impacting Morgan Stanley this week:
- Positive Sentiment: Morgan Stanley’s investment management arm, together with Ridgeback Group, agreed to acquire Metra Living, a UK private rental business, for about £1.045 billion. The deal expands MS into residential rental assets and highlights its ability to deploy capital into new fee-generating businesses. Morgan Stanley Buys Into UK Rentals With £1.045b Metra Living Deal
- Positive Sentiment: Investors are also reacting to Morgan Stanley’s strong recent operating results: the firm posted Q1 EPS of $3.43, topping estimates, and revenue of $20.58 billion, also ahead of expectations, with year-over-year revenue growth of 16%. That supports the view that fundamentals remain solid after the stock’s big run. Morgan Stanley stock performance and earnings background
- Positive Sentiment: News that Morgan Stanley is part of the bank group working on possible OpenAI and Anthropic IPOs adds another potential catalyst, since high-profile tech listings could boost advisory and capital markets fees if they move forward. OpenAI, Anthropic IPOs Spark Battle Between Goldman And Morgan Stanley
- Neutral Sentiment: Several commentary pieces also frame MS as a long-term momentum name and note that the stock has been trading near its highs, which may be attracting trend-following buyers rather than pointing to a single new catalyst. Why Morgan Stanley is a Top Momentum Stock for the Long-Term
Morgan Stanley Price Performance
Morgan Stanley (NYSE:MS – Get Free Report) last announced its earnings results on Wednesday, April 15th. The financial services provider reported $3.43 EPS for the quarter, beating analysts’ consensus estimates of $3.02 by $0.41. Morgan Stanley had a return on equity of 17.70% and a net margin of 14.65%.The company had revenue of $20.58 billion during the quarter, compared to the consensus estimate of $19.23 billion. During the same quarter in the prior year, the company earned $2.60 earnings per share. The firm’s revenue for the quarter was up 16.0% on a year-over-year basis. On average, equities research analysts anticipate that Morgan Stanley will post 11.9 earnings per share for the current year.
Morgan Stanley Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Thursday, April 30th were given a dividend of $1.00 per share. This represents a $4.00 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend was Thursday, April 30th. Morgan Stanley’s payout ratio is presently 36.23%.
Analyst Ratings Changes
Several research analysts have recently issued reports on the stock. BMO Capital Markets raised their target price on shares of Morgan Stanley from $190.00 to $220.00 and gave the stock an “outperform” rating in a report on Monday, April 20th. The Goldman Sachs Group upped their price target on shares of Morgan Stanley from $186.00 to $205.00 and gave the company a “neutral” rating in a report on Thursday, April 16th. Barclays increased their price target on shares of Morgan Stanley from $219.00 to $230.00 and gave the company an “overweight” rating in a research report on Thursday, April 16th. Citizens Jmp reissued a “market perform” rating on shares of Morgan Stanley in a report on Thursday, April 16th. Finally, Zacks Research cut shares of Morgan Stanley from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 27th. Twelve investment analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $206.35.
View Our Latest Analysis on MS
Insiders Place Their Bets
In other Morgan Stanley news, insider Daniel A. Simkowitz sold 14,690 shares of the company’s stock in a transaction on Friday, April 17th. The shares were sold at an average price of $189.24, for a total value of $2,779,935.60. Following the completion of the transaction, the insider directly owned 365,802 shares in the company, valued at approximately $69,224,370.48. This represents a 3.86% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Andrew M. Saperstein sold 51,668 shares of the firm’s stock in a transaction dated Thursday, April 16th. The stock was sold at an average price of $188.59, for a total transaction of $9,744,068.12. Following the completion of the sale, the insider directly owned 282,142 shares of the company’s stock, valued at approximately $53,209,159.78. This represents a 15.48% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 77,476 shares of company stock worth $14,644,762. 0.17% of the stock is currently owned by corporate insiders.
Morgan Stanley Profile
Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.
The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.
Further Reading
- Five stocks we like better than Morgan Stanley
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.
